Lack of association between urinary iodine excretion and successful thyroid ablation in thyroid cancer patients

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 1, 2010, Pages 230-237

  Tala Jury, Hernan P ^b   Castagna, Maria Grazia ^b   Fioravanti, Carla ^b   Cipri, Claudia ^b   Brianzoni, Ernesto ^a   Pacini, Furio ^b  

^a MACERATA HOSPITAL   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE; IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; THYROGLOBULIN BLOOD LEVEL; THYROID ABLATION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; TREATMENT OUTCOME; URINARY EXCRETION; WHOLE BODY SCINTISCANNING;

EID: 75149134230     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1624     Document Type: Article

References (20)

1. Edmonds CJ, Hayes S, Kermode JC, Thompson BD 1977 Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol 50: 799-807
2. Sisson JC 2002 Practical dosimetry of 131I in patients with thyroid carcinoma. Cancer Biother Radiopharm 17:101-105
3. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91:926-932
4. Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow KS, Ghossein R, Tuttle RM 2002 A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. J Nucl Med 43:1482-1488
5. Pacini F, Castagna MG 2008 Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer. Best Pract Res Clin Endocrinol Metab 22:1009-1021
6. Chianelli M, Todino V, Graziano FM, Panunzi C, Pace D, Guglielmi R, Signore A, Papini E 2009 Lowdose (2.0 GBq; 54 mCi) radioiodine post-surgical remnant ablation in thyroid cancer: comparison between hormone withdrawal and use of rhTSH in low risk patients. Eur J Endocrinol 160:431-436
7. Pilli T, Brianzoni E, Capoccetti F, Castagna MG, Fattori S, Poggiu A, Rossi G, Ferretti F, Guarino E, Burroni L, Vattimo A, Cipri C, Pacini F 2007 A comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab 92:3542-3546
8. Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Turco A, Mariani G 2006 Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of postsurgical thyroid remnants. Nucl Med Commun 27:627-632
9. Maxon HR, Thomas SR, Boehringer A, Drilling J, Sperling MI, Sparks JC, Chen IW 1983 Low iodine diet in I-131 ablation of thyroid remnants. Clin Nucl Med 8:123-126
10. Park 2nd JT, Hennessey JV 2004 Two-week low iodine diet is necessary for adequate outpatient preparation for radioiodine rhTSH scanning in patients taking levothyroxine. Thyroid 14:57-63
11. Tomoda C, Uruno T, Takamura Y, Ito Y, Miya A, Kobayashi K, Matsuzuka F, Amino N, Kuma K, Miyauchi A 2005 Reevaluation of stringent low iodine diet in outpatient preparation for radioiodine examination and therapy. Endocr J 52:237-240
12. Lakshmanan M, Schaffer A, Robbins J, Reynolds J, Norton J 1988 A simplified low iodine diet. Clin Nucl Med 13:866-868
13. Golsings BM 1975 Effect of low iodine diet on 131I therapy in follicular thyroid carcinomata. J Endocrinol 64:30P
14. Morris LF, Wilder MS, Waxman AD, Braunstein GD 2001 Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. Thyroid 11:749-755
15. Pluijmen M, Eustatia-Rutten C, Goslings BM, Stokkel MP, Pereira Arias AM, Diamant M, Rojmin J, Smit JW 2003 Effects of low iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 58:428-435
16. Barakat RM, Ingbar SH 1965 The effect of acute iodine depletion on thyroid function in man. J Clin Invest 44:1117-1124
17. Maruca J, Santner S, Miller K, Santen RJ 1984 Prolonged iodine clearance with depletion regimen for thyroid carcinoma: concise communication. J Nucl Med 25:1089-1093
18. Greene FL, Page DL, Fleming ID, Fritz A, Balch C, Haller D, Marrow M, eds 2002 AJCC cancer staging handbook: TNM classification of malignant tumors. 6th ed. New York: Springer-Verlag
19. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896
20. Feldt-Rasmussen U, Profilis C, Colinet E, Black E, Bornet H, Bourdoux P, Carayon P, Ericsson UB, Koutras DA, Lamas de Leon L, DeNayer P, Pacini F, Palumbo G, Santos A, Schlumberger M, Seidel C, Van Herle AJ, DeVijlder JJ 1996 Human thyroglobulin reference material (CRM 457). 2nd part: physicochemical characterization and certification. Ann Biol Clin 54:343-348